Immunogenicity of ALVAC-HIV vCP1521 in Infants of HIV-1 Infected Women in Uganda (HPTN 027): the first pediatric HIV vaccine trial in Africa

OBJECTIVE: Maternal-to-child-transmission of HIV-1 infection remains a significant cause of HIV-1 infection despite successful prevention strategies. Testing protective HIV-1 vaccines remains a critical priority. The immunogenicity of ALVAC-HIV vCP1521 (ALVAC) in infants born to HIV-1 infected women...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kaleebu, Pontiano, Njai, Harr Freeya, Wang, Lei, Jones, Norman, Ssewanyana, Isaac, Richardson, Paul, Kintu, Kenneth, Emel, Lynda, Musoke, Philippa, Fowler, Mary Glenn, Ou, San-San, Guay, Laura, Andrew, Philip, Baglyos, Lynn, team, Huyen Cao
Formato: Artigo
Lenguaje:Inglês
Publicado: 2014
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4171956/
https://ncbi.nlm.nih.gov/pubmed/24091694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.qai.0000435600.65845.31
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares